Показати скорочений опис матеріалу
dc.contributor.author | Meshmash, Hind | |
dc.contributor.author | Scientific Supervisor: Yaschchuk, I. S. | |
dc.date.accessioned | 2025-02-10T11:07:37Z | |
dc.date.available | 2025-02-10T11:07:37Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Meshmash Hind. Ality change management as a factor in the development of a pharmaceutical company. Сучасні теоретичні та практичні аспекти клінічної медицини для здобувачів освіти другого (магістерського) рівня [електронне видання] : наук.-практ. конф. з міжнар. участю, присвячена 95-річчю з дня народження Ю. Л. Курака, Одеса, 25–26 квітня 2024 року : тези доп. – Одеса : ОНМедУ, 2024. – P. 98–99. | uk_UA |
dc.identifier.uri | https://repo.odmu.edu.ua:443/xmlui/handle/123456789/16892 | |
dc.description.abstract | Modern pharmaceutical companies operate in the conditions of global competition, where supply prevails over demand, and consumer demands for product quality are growing. This places additional requirements on the development process: on the one hand, it complicates development, and on the other hand, it creates favorable conditions for innovation and change. The pharmaceutical environment, which dynamically evolves, requires continuous adaptation and can become the basis for achieving a leading position when a new technology or product emerges. Changes for pharmaceutical enterprises are becoming a constant phenomenon and a necessary condition for ensuring competitive advantages, increasing market value and integrating enterprises into the global economic context. That is why it is important for the pharmaceutical industry to find new strategies and improve existing change management tools. | uk_UA |
dc.language.iso | en | uk_UA |
dc.subject | the pharmaceutical environment | uk_UA |
dc.title | Ality change management as a factor in the development of a pharmaceutical company | uk_UA |
dc.type | Article | uk_UA |